A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...
Researchers have made a “massive step forwards” with the discovery of a major cause of inflammatory bowel disease (IBD), as well as finding that existing drugs could be used to treat the condition.
Researchers found a molecule that can both help the intestines to heal after damage and suppress tumour growth in colorectal cancer. The discovery could lead to new treatments for inflammatory bowel ...
Anti-TNF therapy during the early stages of pregnancy was associated with a decrease in the risk for gestational diabetes among women with inflammatory bowel disease.